EFFECT OF DRUG TESTOSTERONE ON THE CONTENT OF RAGE AND INFLAMMATORY TRANSCRIPTION FACTOR NF-KB IN RAT TESTICULAR TISSUE WITH A FRUCTOSE-ENRICHED DIET



Cite item

Full Text

Abstract

Abstract

Hypogonadism develops in diabetes mellitus (DM) and metabolic syndrome (MS). Testosterone replacement therapy can be applied, but its effect on spermatogenesis is controversial. Hyperglycemia promotes the accumulation of advanced glycation end products. Cellular receptors for advanced glycation end products (RAGE) trigger inflammatory responses through the proinflammatory transcription factor NF-kB. This signaling pathway may be involved in the disruption of spermatogenesis in hyperglycemia and during testosterone therapy.

The aim of the study is to evaluate the effect of testosterone on RAGE and NF-kB levels in rat’s testicles for DM and MS.

The data were obtained using Western blotting and immunofluorescence studies. The experiments were carried out on young rats. Animals were randomly divided into the groups: K (vivar control, 6), metabolic syndrome (MS, 5), metabolic syndrome + testosterone (MS + Tn, 8), testosterone (Tn, 4).

No significant changes in the content of RAGE and NF-kB in the testicular tissue of rats with hyperglycemia were found, which may be due to insufficient duration of hyperglycemia and mechanisms that inhibit inflammation.

The content of RAGE in testicular tissues was significantly higher in the MS + Tn and Tn groups (Western blotting) and in the MS + Tn group (immunofluorescence method). It is likely that testosterone, including against the background of hyperglycemia, causes an increase in the RAGE content in testicular tissue.

No significant changes in the NF-kB content in the testes were found. It seems that the inflammatory cascade realized with the participation of this factor is not activated in the testicles.

There are no significant changes in the testicular weight to body weight ratio and the lumen area to thickness area ratio of the seminiferous tubules. These facts indicate the absence of atrophic changes in the rat testes.

So, hyperglycemia for 6 weeks does not cause an increase in the RAGE and NF-kB levels in the rat testes; testosterone increases the RAGE content in the rat testicles both against the background of hyperglycemia and in the intact organism; despite the increase in RAGE, activation of the NF-kB-dependent proinflammatory cascade is not realized; atrophy in the testicular tissue of rats do not occur.

About the authors

Natalya Gennadievna Ovchinina

Izhevsk State Medical Academy, Department of Pathological Physiology and Immunology

Email: ntly.82@mail.ru
SPIN-code: 3811-8710
Scopus Author ID: 24766615500

PhD, associate Professor of the Department of Pathological Physiology and Immunology

Russian Federation, Kommunarov str. 281, Izhevsk 426056, Russian Federation

Maria Anatolyevna Urakova

Izhevsk State Medical Academy, Department of Pathological Physiology and Immunology

Email: urakova-mariya@yandex.ru
SPIN-code: 6813-4667
Scopus Author ID: 57189019065

PhD, associate Professor of the Department of Pathological Physiology and Immunology

Russian Federation, Kommunarov str. 281, Izhevsk 426056, Russian Federation

Vladimir Alekseevich Protopopov

Izhevsk State Medical Academy, Department of Pathological Physiology and Immunology

Email: patofiz@igma.udm.ru
ORCID iD: 0000-0003-4058-8155
SPIN-code: 9923-1659
Scopus Author ID: 57211161098

Assistant Professor, Department of Pathological Physiology and Immunology

Russian Federation, Kommunarov str. 281, Izhevsk 426056, Russian Federation

Alexey Vasilievich Sekunov

Izhevsk State Medical Academy, Department of Pathological Physiology and Immunology

Email: patofiz@igma.udm.ru
SPIN-code: 5177-8125

PhD, Assistant Professor, Department of Pathological Physiology and Immunology

Russian Federation, Kommunarov str. 281, Izhevsk 426056, Russian Federation

Irina Georgievna Bryndina

Izhevsk State Medical Academy, Department of Pathological Physiology and Immunology

Author for correspondence.
Email: i_bryndina@mail.ru
ORCID iD: 0000-0003-4099-4508
SPIN-code: 1921-2677
Scopus Author ID: 6507928155

PhD, head of Department, professor of the Department of Pathological Physiology and Immunology

Russian Federation, Kommunarov str. 281, Izhevsk 426056, Russian Federation

References

  1. Uspenskaya Y.A., Komleva Y.K., Pozhilenkova E.A., Salmin V.V., Lopatina O.L., Fursov A.A., Lavrentiev P.V., Belova O.A., Salmina A.B. Ligands of RAGE-Proteins: Role in Intercellular Communication and Pathogenesis of Inflammation. Vestn. Ross. Akad. Med. Nauk, 2015, Vol. 70, no.6, pp. 694-703.
  2. Bierhaus A., Nawroth P.P. Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications. Diabetologia, 2009, Vol. 52, no. 11, pp.2251–2263.
  3. Caliber M., Saad F. Curr Opin Testosterone therapy for prevention and reversal of type 2 diabetes in men with low testosterone. Pharmacol, 2021 Vol. 58, pp. 83-89.
  4. Chan A.M.L., Ng A.M.H., Mohd Yunus M.H., Idrus R.B.H., Law J.X., Yazid M.D., Chin K.Y., Shamsuddin S.A., Lokanathan Y. Recent Developments in Rodent Models of High-Fructose Diet-Induced Metabolic Syndrome: A Systematic Review. Nutrients, 2021, Vol.13, pp.1-21.
  5. Cheng Y.S., Dai D.Z., Ji H., Zhang Q., Dai Y. Sildenafil and FDP-Sr attenuate diabetic cardiomyopathy by suppressing abnormal expression of myocardial CASQ2, FKBP12.6, and SERCA2a in rats. Ac. Pharmacol. Sin., 2011, Vol. 32, no.4, pp. 441-448.
  6. Corona G., Vena W., Pizzocaro A., Vignozzi L., Sforza A., Maggi M. Testosterone therapy in diabetes and pre-diabetes. Andrology, 2023, Vol. 11, no. 2, pp.204-214.
  7. Desai A., Yassin M., Cayetano A., Tharakan T., Jayasena C.N., Minhas S. Understanding and managing the suppression of spermatogenesis caused by testosterone replacement therapy (TRT) and anabolic-androgenic steroids (AAS). Ther. Adv. Urol., 2022, Vol. 14, pp. 1-18.
  8. Dutta S., Majzoub A., Agarwal A. Oxidative stress and sperm function: a systematic review on evaluation and management. Arab. J. Urol., 2019, Vol.17, no. 2, pp.87-97.
  9. Ebrahimi F., Christ-Crain M. Metabolic syndrome and hypogonadism – two peas in a pod. Swiss Med Wkly, 2016, Vol. 21; pp. 146:w14283.
  10. Kang J., Chen R., Tharakan T., Minhas S. Novel androgen therapies including selective androgen receptor modulators. Best Pract Res Clin Endocrinol Metab, 2022, Vol. 36, no. 5, pp. 1-17.
  11. Wang Y., Wang H., Piper M.G., McMaken S., Mo X., Opalek J., Schmidt A.M., Marsh C.B. sRAGE induces human monocyte survival and differentiation. J. Immunol., 2010, Vol. 185, no. 3, pp.1822-1835.
  12. Yan S.F., Ramasamy R., Schmidt A.M. Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging. Biochem. Pharmacol., 2010, Vol. 79, no. 10, pp. 1379-1386.
  13. Zhang J., Li X., Cai Z., Li H., Yang B. Association between testosterone with type 2 diabetes in adult males, a meta-analysis and trial sequential analysis. Aging Male, 2020, Vol. 23, no. 5, pp. 607-618.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) Ovchinina N., Urakova M., Protopopov V., Sekunov A., Bryndina I.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № 77 - 11525 от 04.01.2002.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies